Abstract Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated considerable efficacy in the treatment of diabetes and obesity, it is essential to recognize that their use is associated with certain intrinsic risks that must not be disregarded
I draw partly upon the books: Turning Up the Heat: Urban Political Ecology for a Climate Emergency (Kaika, Keil, Mandler and Tzaninis (eds), 2023
The Redox State of Cytochrome C Modulates Resistance to Methotrexate in Human MCF7 Breast Cancer Cells
Fewer or More Manageable Side Effects Many people explore microdosing GLP-1 medications in hopes of reducing common GLP-1 side effects such as nausea, vomiting, diarrhea, and appetite suppression
To receive it in your inbox every Thursday, and read articles like this first, sign up here
Providers who work with growth hormone secretagogues often notice this same pattern in practice: patients mention improved sleep quality and reduced next-day fatigue well before they report changes in strength or muscle definition